The natural history of nonalcoholic fatty liver disease: A population-based cohort study

Gastroenterology

Volumn 129, Issue 1, 2005, Pages 113-121

  Adams, Leon A ^a   Lymp, James F ^b   St Sauver, Jenny ^b   Sanderson, Schuyler O ^b   Lindor, Keith D ^a   Feldstein, Ariel ^a   Angulo, Paul ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HISTORY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NONALCOHOLIC FATTY LIVER; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; SEX DIFFERENCE; STANDARDIZATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES;

EID: 22344452893     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.04.014     Document Type: Article

References (35)

1. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, J.S. Marks Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 2003 76 79
2. E.S. Ford, W.H. Giles, W.H. Dietz Prevalence of the metabolic syndrome among US adults findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359
3. K.M. Flegal, M.D. Carroll, C.L. Ogden, C.L. Johnson Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723 1727
4. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, J.C. Cohen, S.M. Grundy, H.H. Hobbs Prevalence of hepatic steatosis in an urban population in the United States impact of ethnicity Hepatology 40 2004 1387 1395
5. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
6. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, C.J. Driscoll Cryptogenic cirrhosis clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
7. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, P. Carucci, A. Musso, P. De Paolis, L. Capussotti, M. Salizzoni, M. Rizzetto Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to heptocellular carcinoma Gastroenterology 123 2002 134 140
8. R.G. Lee Nonalcoholic steatohepatitis a study of 49 patients Hum Pathol 20 1989 594 598
9. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, L.W. Powell The natural history of nonalcoholic steatohepatitis a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
10. M.R. Teli, O.F. James, A.D. Burt, M.K. Bennett, C.P. Day The natural history of nonalcoholic fatty liver a follow-up study Hepatology 22 1995 1714 1719
11. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, A.J. McCullough Nonalcoholic fatty liver disease a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
12. S. Dam-Larsen, M. Franzmann, I.B. Andersen, P. Christoffersen, L.B. Jensen, T.I. Sorensen, U. Becker, F. Bendtsen Long term prognosis of fatty liver risk of chronic liver disease and death Gut 53 2004 750 755
13. C.D. Evans, K.A. Oien, R.N. MacSween, P.R. Mills Non-alcoholic steatohepatitis a common cause of progressive chronic liver injury? J Clin Pathol 55 2002 689 692
14. L.J. Melton III History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
15. United States Census Bureau D.L. Evans, J.L. Price, W.G. Barron Profiles of demographic characteristics, 2000 Census of Population and Housing, Minnesota 2001
16. J. Ludwig, T.R. Viggiano, D.B. McGill, B.J. Oh Nonalcoholic steatohepatitis Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434 438
17. S.H. Caldwell, D.M. Crespo The spectrum expanded cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease J Hepatol 40 2004 578 584
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
19. World Health Organization Report of a WHO consultation definition of metabolic syndrome in definition, diagnosis and classification of diabetes mellitus 1999 World Health Organization, Department of Noncommunicable Disease Surveillance Geneva
20. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, B.R. Bacon Nonalcoholic steatohepatitis a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
21. B.A. Neuschwander-Tetri, S.H. Caldwell Nonalcoholic steatohepatitis summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
22. F. Ederer The relative survival rate a statistical methodology Natl Cancer Inst Monograph 6 1961 101 121
23. 2000 Minnesota Health Statistics Annual Summary, General Mortality Minnesota Department of Health 2001
24. J. Hui, J.G. Kench, S. Chitturi, A. Sud, G.C. Farrell, K. Byth, P. Hall, M. Khan, J. George Long term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C Hepatology 38 2003 420 427
25. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
26. E.E. Calle, M.J. Thun, J.M. Petrelli, C. Rodriguez, C.W. Heath Jr Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 341 1999 1097 1105
27. S.H. Saydah, C.M. Loria, M.S. Eberhardt, F.L. Brancati Abnormal glucose tolerance and the risk of cancer death in the United States Am J Epidemiol 157 2003 1092 1100
28. G.N. Ioannou, N.S. Weiss, K.V. Kowdley, J.A. Dominitz Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study Gastroenterology 125 2003 1053 1059
29. H.B. El-Serag, T. Tran, J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
30. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan Diabetes prevention program research group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
31. K.F. Eriksson, F. Lindgarde No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise Diabetologia 41 1998 1010 1016
32. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
33. S. Malik, N.D. Wong, S.S. Franklin, T.V. Kamath, G.J. L'Italien, J.R. Pio, G.R. Williams Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 2004 1245 1250
34. E.S. Ford The metabolic syndrome and mortality from cardiovascular disease and all-causes findings from the National Health and Nutrition Examination Survey II Mortality Study Atherosclerosis 173 2004 309 314
35. K.J. Hunt, R.G. Resendez, K. Williams, S.M. Haffner, M.P. Stern National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study Circulation 110 2004 1251 1257